VIT C/K3 in Cancer Treatment!
Cancer is defined by cell cycle deregulation and uncontrolled growth. It is the second leading cause of death in the world.
We now have a new hope the combination of intravenous Vitamin C and K3 in 100:1 ratio known as Apatone. This specific combination causes a form of cell necrosis called autoschizis…it is KILLING cancer. Researchers started experimenting with a combination of vitamin C and Vitamin K3 (CK3) and watched as cancer cells…it killed them.
he best results?
The Science
Before we can get into how the specific combination of Vitamin CK3 kills cancer, we must first get a better understanding of cancer cells.
From a biochemical point of view, cancer cells have some remarkable features:
- They are deficient in DNase activity
- They have low activities of antioxidant enzymes
- They show high rates of glycolysis
- And most of cancer cells accumulate Vitamin C
- The inhibition of both alkaline DNase and acid DNase has been reported in non-necrotic cancer cells at early stages of experimental carcinogenesis. On the other hand, the reactivation of these enzymes has also been seen in the early stages of spontaneous and/or induced tumor cell death. Therefore, the use of compounds able to activate such endonucleases opens the possibility of a new therapeutic approach for cancer treatment…Vitamins C and K3 reactivate acid and alkaline DNases!
The big question is, can that combination work with cancer?
It is well known that vitamin C is cytotoxic against malignant melanoma cells, human leukaemia cells, neuroblastoma cells, tumour ascites cells, acute lymphoblastic leukaemia, and epidermoid carcinoma. It is also well know that vitamin K3 is cytotoxic against tumors of breast, stomach, lung, colon, nasopharyngeal, cervix, liver, leukaemia, and lymphoma cell lines.
What The
Researchers Did
Researchers combined vitamins C and K3 at ratio of 100:1 after in vivo administration in tumor-bearing mice produced and found the following:
Cancer growth inhibition in transplant-able liver tumor (TLT)-bearing mice with an increase in life span (ILS) of 45.8%. Neither vitamin C nor vitamin K3 administered alone has any significant effect on the life span of TLT-bearing animals. It must be in the 100:1 ratio.
Selective potentiation of tumor chemotherapy. For instance, while cyclophosphamide alone, at a single sub-therapeutic dose of 80 mg/kg body weight increased the life span by 23%, its association with CK3, increased the life span by 59.5%
Sensitization of tumors resistant to some drugs occurs. The pretreatment of TLT-bearing mice with CK3 before injection of Oncovin increases the life span by 97.3%.
Additionally examinations of CK3-treated mice did not indicate any sign of toxicity in normal organ and tissues.
But How Does The CK3
Kill The Cancer Cells?
Both morphological examination and flow cytometry analysis allow us to see whether cells are dying by necrosis (triggered cell death) or apoptosis (normal cell death).
This is important because we need to know if the cancer cells are dying because they are being “triggered” to so or if it’s just part of their normal cell cycle.
On the basis of these parameters, cancer cells treated by CK3 die principally by cell necrosis, but interestingly enough share some characteristics of both necrosis and apoptosis
Pretreatment with this vitamin C/K3 combination appears to potentiate the effect of chemotherapy and radiation. It also appears to be nontoxic, leaving normal cells unaffected.
Beating Cancer
As a Whole
Hyperbaric oxygen and ozone therapy are also offered at our practice. In the studies the damage vitc/k3 did to cancer cells was limited to the amount of oxygen saturation that was in the sample.
This is how we can align Linus Pauling and Otto Warburg. The 100:1 ratio of vitamin C and K3 can allow 400%+ more C into the cancer cell and the combination of ozone and hyperbaric oxygen floods the cancer cells with oxygen thus giving the patient the best chance for success.
